SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence
Opioid-use Disorder
About this trial
This is an interventional treatment trial for Opioid-use Disorder focused on measuring opioid use disorder, buprenorphine, treatment adherence
Eligibility Criteria
Inclusion Criteria:
- Present with symptoms of Opioid Use Disorder
- Eligible of receipt of buprenorphine-naloxone medication as determined by Study Doctor
- Access to a telephone
Exclusion Criteria:
- Under 18 years old
- Unable to understand spoken English
Sites / Locations
- University of Tennessee Health Science Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Contingency Management (CM)
Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM)
BSM+CM
CM is a behavioral method that employs external rewards for target behavior. Participants will receive gift cards for adhering to treatment (attending physician visits and being adherent to buprenorphine-naloxone) for their first 4 clinic visits.
Participants will receive the BSM intervention at 4 timepoints.
BSM+CM is a combination of the two other arms. Participants may be randomized to this arm only in stage 2 of the SMART design.